Grantham, Mayo, Van Otterloo & Co (GMO)’s Boston Scientific BSX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$941K	Buy	+15,000	New	+$1.2M	﹤0.01%	513
2020 Q2	–	Sell	-103,938	Closed	-$3.39M	–	758
2020 Q1	$3.39M	Buy	+103,938	New	+$4.06M	0.03%	306
2014 Q1	–	Sell	-78,020	Closed	-$938K	–	572
2013 Q4	$938K	Buy	+78,020	New	+$922K	﹤0.01%	461

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BSX Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Boston Scientific (BSX) in Q1 2026: 15,000 shares worth $941K. The stake represents ﹤0.01% of the portfolio and ranks #513 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in BSX as recently as Q1 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BSX in Q4 2013 and has held it in 3 quarters since. The position peaked at $3.39M in Q1 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 15,000 shares of Boston Scientific worth $941K as of Q1 2026.
Boston Scientific was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q1 2026.
Boston Scientific made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #513 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Boston Scientific in Q4 2013 and has held it in 3 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Boston Scientific position peaked at $3.39M in Q1 2020.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.